These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 16534635)

  • 1. Cytochrome P450 2D6 dependent metabolization of risperidone is inhibited by melperone.
    Köhnke MD; Lutz U; Wiatr G; Schwärzler F; Weller B; Schott K; Buchkremer G
    Eur J Clin Pharmacol; 2006 Apr; 62(4):333-4. PubMed ID: 16534635
    [No Abstract]   [Full Text] [Related]  

  • 2. Cytochrome P450 2D6 deficiency and its clinical relevance in a patient treated with risperidone.
    Köhnke MD; Griese EU; Stösser D; Gaertner I; Barth G
    Pharmacopsychiatry; 2002 May; 35(3):116-8. PubMed ID: 12107857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melperone but not bisoprolol or metoprolol is a clinically relevant inhibitor of CYP2D6: evidence from a therapeutic drug monitoring survey.
    Hefner G; Unterecker S; Shams ME; Wolf M; Falter T; Haen E; Hiemke C
    J Neural Transm (Vienna); 2015 Nov; 122(11):1609-17. PubMed ID: 25940834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A pilot study on risperidone metabolism: the role of cytochromes P450 2D6 and 3A.
    Bork JA; Rogers T; Wedlund PJ; de Leon J
    J Clin Psychiatry; 1999 Jul; 60(7):469-76. PubMed ID: 10453802
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of schizophrenia with melperone augmentation in a patient with phenotypic CYP2D6 ultrarapid metabolization: a case report.
    Gahr M; Gastl R; Kölle MA; Schönfeldt-Lecuona C; Freudenmann RW
    J Med Case Rep; 2012 Feb; 6():49. PubMed ID: 22309430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of multiple inhibitors or substrates of cytochrome P450 2D6 on plasma risperidone levels in patients on polypharmacy.
    Mannheimer B; von Bahr C; Pettersson H; Eliasson E
    Ther Drug Monit; 2008 Oct; 30(5):565-9. PubMed ID: 18728628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum prolactin levels, plasma risperidone levels, polymorphism of cytochrome P450 2D6 and clinical response in patients with schizophrenia.
    Wang L; Yu L; Zhang AP; Fang C; Du J; Gu NF; Qin SY; Feng GY; Li XW; Xing QH; He L
    J Psychopharmacol; 2007 Nov; 21(8):837-42. PubMed ID: 17715206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interpreting serum risperidone concentrations.
    Boerth JM; Caley CF; Goethe JW
    Pharmacotherapy; 2005 Feb; 25(2):299-302. PubMed ID: 15767244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P450 3A inhibitor itraconazole affects plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients.
    Jung SM; Kim KA; Cho HK; Jung IG; Park PW; Byun WT; Park JY
    Clin Pharmacol Ther; 2005 Nov; 78(5):520-8. PubMed ID: 16321618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in weight and body mass index during treatment with melperone, clozapine and typical neuroleptics.
    Bobo WV; Jayathilake K; Lee MA; Meltzer HY
    Psychiatry Res; 2010 Apr; 176(2-3):114-9. PubMed ID: 20199813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CYP2D6 genotyping in paediatric patients with autism treated with risperidone: a preliminary cohort study.
    Youngster I; Zachor DA; Gabis LV; Bar-Chaim A; Benveniste-Levkovitz P; Britzi M; Soback S; Ziv-Baran T; Berkovitch M
    Dev Med Child Neurol; 2014 Oct; 56(10):990-4. PubMed ID: 24828442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A population pharmacokinetic evaluation of the influence of CYP2D6 genotype on risperidone metabolism in patients with acute episode of schizophrenia.
    Locatelli I; Kastelic M; Koprivsek J; Kores-Plesnicar B; Mrhar A; Dolzan V; Grabnar I
    Eur J Pharm Sci; 2010 Oct; 41(2):289-98. PubMed ID: 20599499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of desipramine hydroxylation (Cytochrome P450-2D6) in vitro by quinidine and by viral protease inhibitors: relation to drug interactions in vivo.
    von Moltke LL; Greenblatt DJ; Duan SX; Daily JP; Harmatz JS; Shader RI
    J Pharm Sci; 1998 Oct; 87(10):1184-9. PubMed ID: 9758674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of the CYP2D6*10 alleles and co-medication with CYP2D6-dependent drugs on risperidone metabolism in patients with schizophrenia.
    Yagihashi T; Mizuno M; Chino B; Sato Y; Sakuma K; Takebayashi T; Takao T; Kosaki K
    Hum Psychopharmacol; 2009 Jun; 24(4):301-8. PubMed ID: 19387994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relevance of CYP2D6 variability in first-episode schizophrenia patients treated with risperidone.
    Barteček R; Juřica J; Zrůstová J; Kašpárek T; Pindurová E; Žourková A
    Neuro Endocrinol Lett; 2012; 33(2):236-44. PubMed ID: 22592207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risperidone-related weight gain: genetic and nongenetic predictors.
    Lane HY; Liu YC; Huang CL; Chang YC; Wu PL; Lu CT; Chang WH
    J Clin Psychopharmacol; 2006 Apr; 26(2):128-34. PubMed ID: 16633140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic study on risperidone long-acting injection: influence of cytochrome P450 2D6 and pregnane X receptor on risperidone exposure and drug-induced side-effects.
    Choong E; Polari A; Kamdem RH; Gervasoni N; Spisla C; Jaquenoud Sirot E; Bickel GG; Bondolfi G; Conus P; Eap CB
    J Clin Psychopharmacol; 2013 Jun; 33(3):289-98. PubMed ID: 23609392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severe adverse drug events under combination of nortriptyline and melperone due to pharmacokinetic interaction.
    Hefner G; Geschke K; Hiemke C
    J Clin Psychopharmacol; 2014 Jun; 34(3):394-6. PubMed ID: 24743723
    [No Abstract]   [Full Text] [Related]  

  • 19. Constituents of Indonesian medicinal plant Averrhoa bilimbi and their cytochrome P450 3A4 and 2D6 inhibitory activities.
    Auw L; Subehan ; Sukrasno ; Kadota S; Tezuka Y
    Nat Prod Commun; 2015 Jan; 10(1):57-62. PubMed ID: 25920220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it possible to predict the clinical effects of neuroleptics from animal data? Part V: From haloperidol and pipamperone to risperidone.
    Janssen PA; Awouters FH
    Arzneimittelforschung; 1994 Mar; 44(3):269-77. PubMed ID: 7514873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.